Repligen (RGEN) Tops Q3 EPS by 9c. Updates Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $139.79 +1.73%
EPS Growth %: +21.6%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
CCEL, SLP, TMQ, More
EPS Growth %: +21.6%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.77, $0.09 better than the analyst estimate of $0.68. Revenue for the quarter came in at $200.7 million versus the consensus estimate of $192.68 million.
GUIDANCE:
Repligen sees FY2022 EPS of $3.15-$3.20, versus the consensus of $3.20. Repligen sees FY2022 revenue of $795-805 million, versus the consensus of $804 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Simply Good Foods (SMPL) Tops Q3 EPS by 7c; offers outlook
- AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
- Broadstone Net Lease (BNL) PT Raised to $24 at KeyBanc
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
